3D Multisegment Foot Model Used for the Clinical Outcome After Ankle and Hindfoot Reconstruction
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Mar 29, 2021
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special 3D foot model can help doctors predict and improve the outcomes for patients who undergo surgery for ankle and hindfoot problems. These issues often arise from changes in how the foot and ankle work, and the goal of the surgery is to fix these mechanical problems, leading to better overall health and mobility for patients. The 3D model, which is used at UZ Leuven, allows researchers to analyze many different movement aspects of the foot and ankle, helping to understand how surgery might lead to improvements.
To participate in this trial, you should be between 65 and 74 years old and scheduled for specific types of reconstructive foot surgery, such as treatments for flat feet or ankle fusion. However, if you're under 18, have difficulty walking without assistance, or have significant leg length differences, you won't be eligible to join. Participants can expect to be part of a study that may help improve surgical outcomes for future patients, and your individual health will be taken into account throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Being routinely scheduled for a reconstructive surgical procedure for the following indications or involving the following type of procedure:
- • 1. Any reconstructive procedure for Pes Planus, Pes Plano-valgus, or Posterior Tibial Tendon Dysfunction
- • 2. Tibio-talar arthrodesis or prosthesis
- • 3. Sub-talar -and/or (partial) Chopart - and/or Triple arthrodesis
- • 4. Pantalar arthrodesis with or without inclusion of the Chopart joint
- Exclusion Criteria:
- • Age under 18
- • Need of tools (eg walker or crutches) to walk less than 100m
- • Inability to walk less than 100 m anyway
- • Differences in leg length exceeding 3 cm (measured clinically)
- • Extreme in-or outtoeing
- • Subjects with BMI \> 27.5 require very careful further consideration whether or not the obesity prevents the accurate palpation of anatomical landmarks necessary prior to marker placement. This will be judged on an individual basis.
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, Vlaams Brabant, Belgium
Patients applied
Trial Officials
Giovanni Matricali
Principal Investigator
Universitaire Ziekenhuizen KU Leuven
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials